Wells Fargo Maintains Overweight on Sabra Health Care REIT, Raises Price Target to $22

Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price target from $21 to $22.